Why task world class researchers with commercialisation?
Australia’s landmark R&D review is grappling with how to prioritise research impact over output volume, but misses a fundamental question that cuts to the heart of our innovation problem: do we understand the different skills required for research excellence versus commercial translation?
This question matters. When academic experts, investment professionals, and government officials gather to solve commercialisation challenges, solutions reflect their own professional competencies. The theoretical assumption is research quality determines commercial success. Research experts suggest better industry partnerships. Investment professionals recommend more capital allocation mechanisms. What’s missing are the commercial professionals, those with the experience of translating innovation into market success.
Different jobs require different skills. Both are vitally important for a sophisticated economy, yet consultations assume these competencies are interchangeable. This blind spot has created a systematic failure to translate Australian discoveries into national competitive advantage, leaving decades of stranded research hidden in our world class institutions.
Foundational skills
Academic competency is built through years of specialisation in the scientific method and research integrity operating within institutional structures. These include publication and peer review processes, securing grants, and planning for long-term fundamental research. Researchers aim for increasing citations and academic reputation. Success is advancing human knowledge through research and academic collaboration.
Commercial translation core competencies centre on customer discovery and market validation. They evaluate product-market fit in a competitive landscape. This includes commercial due diligence and risk assessment, measuring operating performance in terms of revenue generation and P&L performance. Focus is on market entry and scaling strategies, and technology integration with existing commercial operations. Commercial leaders know success requires focus on customer need and competitive positioning, with success measured in terms of financial performance.
Investors focus on capital allocation and risk assessment, portfolio management and investment analysis, They are expert in due diligence processes including detailed financial modelling. Investment professionals maximise returns on investment over a targeted period with a defined exit strategy. They care about portfolio performance, and capital efficiency measured through detailed financial analysis.
The competency gap isn’t subtle. Research institutions advance Technology Readiness Levels through systematic investigation. Commercial organisations translate technologies into value through customer-focused market development. Investment professionals excel at capital allocation and financial risk management. Expecting research institutions to develop commercial translation capabilities is like expecting commercial companies to conduct peer review for academic publication.
Risk and Reward
Academic risk management cares about reputation and publications in a long-term research horizon. They manage failure through peer review and academic discussion, with priorities on funding, research advancement and institutional credibility.
Commercial risk management focuses on market opportunity assessment and commercial viability. It operates with short to medium-term commercial horizons and revenue accountability. They measure success through customer satisfaction, revenue growth, and market penetration. Commercial operations respond to failure through adapting quickly to market feedback, aiming to achieve competitive advantage and financial performance.
Academic frameworks are designed for research integrity, while commercial risk frameworks are designed to maximise market opportunity. These are not compatible, and if applied in the wrong context will inadvertently create invisible barriers to collaboration.
This is also true for performance metrics. Academic performance is measured in research output quality and peer-reviewed publications, student outcomes and institutional rankings. Commercial performance is measured by orders, revenue, profits, market share and customer feedback.
Australian Evidence
Current research performance measurement actively discourages commercial engagement. Researchers are rewarded for publications and career progression is based on academic metrics, not economic impact or commercial outcomes. Risk tolerance focuses on research integrity and not market opportunity. Time horizons are measured in research cycles, which differ from economic cycles.
The Australian Research Council’s own analysis reveals this disconnect. Despite substantial investment in resources technology research which has generated over 1,200 patents, there is no systematic measurement of corresponding company performance, revenue generated, or jobs created or maintained in the resources sector.
Australian research is genuinely world-class. The challenge is that academic accountability systems do not align with the performance criteria to meet commercial objectives.
International comparison
Leading innovation economies recognise this competency distinction and design policy accordingly.
The Israeli Innovation Authority requires mandatory economic impact expectations with transparent reporting, creating fundamentally different incentive structures that drive commercial outcomes. Israeli research institutions focus on research excellence while commercial intermediaries handle market translation through specialised commercial capabilities.
The German Fraunhofer model shows success does not come from conducting research, but from operating under commercial leadership and discipline. With 70% industry-funded revenue requirements, Fraunhofer institutes are managed by executives with deep industry experience in understanding customer needs, market dynamics, and commercial performance.
The Canadian Resource Sector proves resource-based economies can develop and retain local innovation. Canadian mining technology (METS) companies consistently translate research outcomes into solutions exported globally.
The New Zealand Callaghan Model provides sustained company-centric support with international market focus from inception. This approach recognises that small economy innovation must be born-global, requiring commercial expertise rather than academic project management.
The pattern is consistent: successful innovation economies leverage complementary capabilities through systematic partnerships rather than expecting individual organisations to excel at incompatible competencies.
Australian commercial leadership
There are many Australian companies big and small, who demonstrate exceptional commercial capability when technologies are developed through commercial processes.
Cochlear Limited achieved global market leadership in medical devices through commercial leadership with deep industry experience. Research priorities were determined by clinical need and market opportunity, not scientific curiosity. International market entry occurred within two years of technology development, with performance measured by market share growth and customer satisfaction, not publications. The company’s success required systematic customer discovery, regulatory navigation, and international scaling—competencies developed through sustained commercial practice.
Visy built packaging and recycling leadership through manufacturing industry experience and international market expertise. Commercial priorities were determined by customer needs and sustainable manufacturing requirements, not academic research alone. International operations developed as core business strategy from inception, with global manufacturing facilities and supply chain management. The company’s success in becoming one of the world’s largest privately-owned packaging and recycling companies required sustained commercial development, customer-focused innovation, and competitive positioning under real market pressure.
CSL Limited success originates from pharmaceutical industry experience and international market expertise. Market-driven research focused on commercial viability and regulatory pathway validation, with global operations as core business strategy from inception. Their commercial processes drive innovation quality through customer accountability.
These companies succeeded because they recognised that commercial translation requires commercial expertise. They invested in customer discovery, market validation, navigating regulatory compliance and competitive positioning, developed through sustained commercial practice, not academic training or investment analysis.
Leveraging complementary strengths
The competency distinction suggests straightforward policy opportunities to leverage Australia’s existing strengths without forcing organisations to develop capabilities outside their expertise.
- Protect research institution excellence by allowing universities and CSIRO to focus on research excellence where they excel. Protect academic institutions from commercial accountability that conflicts with research mission and institutional design. Measure research institutions through research excellence metrics that reflect their priorities.
- Develop commercial translation partners by supporting Australian companies with proven commercial capabilities to become translation engines. Identify companies with existing customer bases, technical integration expertise, and international market access capable of sustained commercialisation. Measure commercial partners through commercial outcome metrics that optimise their market capabilities.
- Create systematic partnership frameworks that connect excellent research institutions with commercially mature Australian companies through collaboration structures that play to each organisation’s strengths. Design partnership models that recognise and support different competency requirements, rather than bundling up competency gaps into ‘innovation hubs’ for retraining and retrofitting.
- Implement performance metrics that evaluates partnerships through successful research-to-market translations which define both research quality and commercial success. Measure economic returns including revenues, export development, customer numbers and jobs created.
Innovation success depends on aligning different strengths, not expecting individual organisations to excel at everything. Australia has both world-class research capabilities, and commercially mature companies. We can connect these through policy frameworks that play to the strengths of each, rather than confusing their different contributions.
Core Competencies
Australia’s innovation challenge isn’t research quality, our research institutions are world-class and should remain focused on research excellence. The challenge is commercial translation, which requires commercial expertise that research institutions cannot and should not be expected to develop.
You wouldn’t ask the Reserve Bank to manage tourism promotion or the Australian Electoral Commission to commercialise medical devices. And certainly wouldn’t want the Bureau of Meteorology running software development programs.
Yet innovation policy routinely expects research institutions to excel at commercial translation. This is a completely different professional competency requiring different skills, different risk frameworks, and different performance accountability systems.
Current approaches fail because they misunderstand fundamental competency requirements. Forcing academic institutions into commercial roles creates systematic failure regardless of research quality or funding levels.
The solution requires recognising that different jobs require different skills. Research excellence requires academic competencies, and our researchers excel at this. Commercial translation requires commercial competencies. Both are essential for innovation success. Neither can substitute for the other.
International evidence demonstrates that successful innovation economies achieve technology export success through specialisation and systematic collaboration, not through academic institutions developing commercial capabilities they’re not designed to possess.
Australia has the research capability and commercial capability necessary for innovation success. We need policy frameworks that connect these strengths appropriately rather than forcing organisations to develop capabilities outside their core expertise.
And perhaps more fundamentally: if commercialisation requires commercial expertise, why do policy makers consistently ask professors for advice on how to deliver commercial outcomes?
Different skills. Different jobs. Both are critical success factors essential for innovation success.
Australian Innovation Exchange – Building the bridge from research to market
